LOQTORZI
NDC 70114-340, toripalimab-tpzi, injection, from Coherus Oncology, Inc..
- Product NDC
- 70114-340
- Status
- Listed
- Labeler
- Coherus Oncology, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761240
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70114-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TORIPALIMAB240 mg/6mL
Pharmacologic classes
Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70114-340-01 | 70114034001 | 1 VIAL, GLASS in 1 CARTON (70114-340-01) / 6 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/82e7921a-1e84-4988-9799-0ad7d19b2a75Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70114-340
Use it
Look up 70114-340 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70114-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70114-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.